Fenwick represented Morphic Holding, Inc. on the deal. Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment...
You must be a Standard 1 Year member to access this content.
Fenwick advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Valtix, a privately...
You must be a Standard 1 Year member to access this content.
Fenwick advised NS1 on the deal. NS1, a provider of network automation SaaS solutions that are designed to enable businesses to deliver content, services and applications...
You must be a Standard 1 Year member to access this content.
Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...
You must be a Standard 1 Year member to access this content.
